↓ Skip to main content

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis

Overview of attention for article published in BMC Women's Health, March 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
Published in
BMC Women's Health, March 2013
DOI 10.1186/1472-6874-13-15
Pubmed ID
Authors

Shonda A Foster, Nianwen Shi, Suellen Curkendall, John Stock, Bong-Chul Chu, Russel Burge, David R Diakun, John H Krege

Abstract

Raloxifene and alendronate are anti-resorptive therapies approved for the prevention and treatment of postmenopausal osteoporosis. Raloxifene is also indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk of invasive breast cancer. A definitive study comparing the fracture effectiveness and rate of breast cancer for raloxifene and alendronate has not been published. The purpose of this retrospective cohort study was to evaluate fracture and breast cancer rates among patients treated with raloxifene or alendronate.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 3%
Unknown 30 97%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 13%
Student > Bachelor 4 13%
Student > Ph. D. Student 3 10%
Researcher 2 6%
Student > Postgraduate 2 6%
Other 7 23%
Unknown 9 29%
Readers by discipline Count As %
Medicine and Dentistry 10 32%
Nursing and Health Professions 5 16%
Agricultural and Biological Sciences 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Earth and Planetary Sciences 1 3%
Other 0 0%
Unknown 10 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2013.
All research outputs
#19,292,491
of 23,881,329 outputs
Outputs from BMC Women's Health
#1,657
of 2,007 outputs
Outputs of similar age
#152,543
of 199,624 outputs
Outputs of similar age from BMC Women's Health
#13
of 15 outputs
Altmetric has tracked 23,881,329 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,007 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,624 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.